Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study Meeting Abstract
| Authors: | Patel, M. R.; Doi, T.; Koyama, T.; Falchook, G. S.; Friedman, C. F.; Piha-Paul, S. A.; Gutierrez, M.; Awad, M. M.; Mattour, A. H.; Satoh, T.; Okamoto, N.; Singh, J.; Yoshizuka, N.; Qian, M.; Qian, X.; Tran, B. P.; Dosunmu, O.; Lu, P.; Johnson, M. L. |
| Abstract Title: | Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S481 |
| End Page: | S482 |
| Language: | English |
| ACCESSION: | WOS:001087480201032 |
| DOI: | 10.1016/j.annonc.2023.09.1876 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 690P -- Source: Wos |
